Quarterly Result
| Natco Pharma Ltd Industry: (Pharmaceuticals - Indian - Bulk Drugs & Formln) |
|---|
|
BSE Code:
524816
ISIN Demat:
INE987B01026
Book Value(₹): 501.20 NSE Symbol:
NATCOPHARM
Div & Yield(%):
0.58
Market Cap(₹ Cr): 15,395.30 P/E(TTM):
17.26
EPS(TTM):
45.47
Face Value(₹): 2.00 |
| Particulars | Jun 2026 (₹ Cr) | Mar 2026 (₹ Cr) | Dec 2025 (₹ Cr) |
|---|---|---|---|
| Gross Sales | 596.60 | 608.80 | 528.80 |
| Excise Duty | 0.00 | 0.00 | 0.00 |
| Net Sales | 596.60 | 608.80 | 528.80 |
| Other Operating Income | 0.00 | 0.00 | 0.00 |
| Other Income | 48.30 | 72.90 | 55.30 |
| Total Income | 644.90 | 681.70 | 584.10 |
| Total Expenditure | 490.60 | 516.40 | 408.50 |
| PBIDT | 154.30 | 165.30 | 175.60 |
| Interest | 9.60 | 9.70 | 8.30 |
| PBDT | 144.70 | 155.60 | 167.30 |
| Depreciation | 42.70 | 45.60 | 42.10 |
| Tax | 11.00 | 5.60 | 26.20 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 16.40 | -105.20 | -7.90 |
| Reported Profit After Tax | 74.60 | 209.60 | 106.90 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 74.60 | 209.60 | 106.90 |
| EPS (Unit Curr.) | 4.17 | 11.70 | 5.97 |
| EPS (Adj) (Unit Curr.) | 4.14 | 11.61 | 5.92 |
| Calculated EPS (Unit Curr.) | 4.17 | 11.71 | 5.97 |
| Calculated EPS (Adj) (Unit Curr.) | 4.14 | 11.62 | 5.92 |
| Calculated EPS (Ann.) (Unit Curr.) | 16.67 | 46.84 | 23.89 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 16.54 | 46.46 | 23.70 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 75.00 |
| Equity | 35.80 | 35.80 | 35.80 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 25.86 | 27.15 | 33.21 |
| PBDTM(%) | 24.25 | 25.56 | 31.64 |
| PATM(%) | 12.50 | 34.43 | 20.22 |